Clinical Trials Directory

Trials / Completed

CompletedNCT04013347

Outcomes of Resection at Different Times Between the End of Neoadjuvant Treatment and Surgery

Evaluation of Anatomopathological, Oncological and Surgical Outcomes in Relation to the Different Times Between the End of Neoadjuvant Treatment and Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
167 (actual)
Sponsor
Campus Bio-Medico University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

Neoadjuvant radio-chemotherapy (NRCT) represents a milestone in the treatment of selected rectal tumours. Ideal time interval between the end of NRCT and surgery is still debated; a 6-8 weeks time interval is considered optimal, but shorter or longer intervals have been associated with better oncological outcomes. Moreover, there is a lack of data about clinical postoperative outcomes and different time intervals after the end of NRCT. Here, effect that different time intervals have on postoperative complications with particular regard to the anastomotic dehiscence have been evaluated. Methods One hundred-sixty-seven patients underwent surgery after long-course NRCT. Three different time intervals were considered: (0-42; 43-56; \>57 days).

Detailed description

Neoadjuvant radio-chemotherapy (NRCT) represents a milestone in the treatment of selected rectal adenocarcinoma. Even though a 6-8 weeks' time interval after the end of NRCT and surgery is considered ideal, the optimal time for surgery is still controversial.

Conditions

Interventions

TypeNameDescription
PROCEDURERectal ResectionLow Anterior Resection and Abdominoperineal Resection

Timeline

Start date
2005-01-01
Primary completion
2015-03-01
Completion
2017-03-21
First posted
2019-07-09
Last updated
2019-07-09

Source: ClinicalTrials.gov record NCT04013347. Inclusion in this directory is not an endorsement.